HEMOBIOTECH INC (HMBT.OB) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 17 transactions totaling $1.2M, demonstrating a bearish sentiment with -$1.1M in net insider flow. The most recent transaction on Oct 26, 2009 involved a purchase of 40,000 shares valued at $10.0K.
No significant insider buying has been recorded for HMBT.OB in the recent period.
No significant insider selling has been recorded for HMBT.OB in the recent period.
Based on recent SEC filings, insider sentiment for HMBT.OB is bearish with an Insider Alignment Score of 2/100 and a net flow of -$1.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at HEMOBIOTECH INC (HMBT.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading HMBT.OB stock, having executed 17 transactions in the past 90 days. The most active insider is Ghassan Nino (Executive), who has made 4 transactions totaling $1.2M.
Get notified when executives and directors at HMBT.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 26, 2009 | Baron Robert | Executive | Purchase | 40,000 | $0.25 | $10.0K | |
| Mar 4, 2009 | J. Rosenblum Mark | Executive | Award | 65,000 | $N/A | $0 | |
| Nov 2, 2008 | Bollon Arthur | Executive | Other | 52,778 | $1.25 | $66.0K | |
| Oct 30, 2008 | Bollon Arthur | Executive | Payment | 130,334 | $1.00 | $130.3K | |
| Oct 30, 2008 | Bollon Arthur | Executive | Option Exercise | 651,668 | $0.20 | $130.3K | |
| Mar 14, 2007 | Nino Ghassan | Executive | Sale | 1,000,000 | $1.17 | $1.2M | Large |
| Jul 13, 2006 | Baron Robert | Executive | Exercise | 17,647 | $1.06 | $18.7K | |
| Jul 13, 2006 | Baron Robert | Executive | Exercise | 17,647 | $1.06 | $18.7K | |
| Mar 20, 2006 | Baron Robert | Executive | Purchase | 3,150 | $1.75 | $5.5K | |
| Mar 17, 2006 | Baron Robert | Executive | Purchase | 1,850 | $1.85 | $3.4K | |
| Feb 23, 2006 | Baron Robert | Executive | Purchase | 5,000 | $1.95 | $9.8K | |
| Nov 21, 2005 | Baron Robert | Executive | Award | 5,000 | $1.55 | $7.8K | |
| Oct 27, 2005 | Baron Robert | Executive | Option Exercise | 7,783 | $1.06 | $8.2K | |
| May 31, 2005 | Nino Ghassan | Executive | Award | 0 | $N/A | $0 | |
| May 31, 2005 | Nino Ghassan | Executive | Award | 0 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 1 | $1.2M | 74.1% |
Exercise(M) | 2 | $138.6K | 8.8% |
Payment(F) | 1 | $130.3K | 8.3% |
Other(J) | 2 | $66.0K | 4.2% |
Exercise (Options)(X) | 2 | $37.4K | 2.4% |
Purchase(P) | 4 | $28.7K | 1.8% |
Award(A) | 5 | $7.8K | 0.5% |
Insider selling pressure at HEMOBIOTECH INC has increased, with 4 insiders executing 17 transactions across all time. Total sales of $1.2M significantly outpace purchases of $28.7K, resulting in a net outflow of $1.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.